Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer

Kennedy, Sean P.; Han, Jeremy Z. R.; Portman, Neil; Nobis, Max; Hastings, Jordan F.; Murphy, Kendelle J.; Latham, Sharissa L.; Cadell, Antonia L.; Miladinovic, Dushan; Marriott, Gabriella R.; O’Donnell, Yolande E. I.; Shearer, Robert F.; Williams, James T.; Munoz, Amaya Garcia; Cox, Thomas R.; Watkins, D. Neil; Saunders, Darren N.; Timpson, Paul; Lim, Elgene; Kolch, Walter; Croucher, David R.

Published in

BioMed Central, Breast Cancer Research, 1(21), 2019

DOI: 10.1186/s13058-019-1127-y

Tools

Export citation

Search in Google Scholar

Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer

Journal article published in 2019 by Sean P. Kennedy, Jeremy Z. R. Han, Neil Portman, Max Nobis, Jordan F. Hastings, Kendelle J. Murphy, Sharissa L. Latham

, Antonia L. Cadell

, Dushan Miladinovic, Gabriella R. Marriott, Yolande E. I. O’Donnell, Robert F. Shearer, James T. Williams, Amaya Garcia Munoz, Thomas R. Cox and other authors.

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving allowed

Upload

Postprint: archiving allowed

Upload

Published version: archiving allowed

Upload

Policy details

Data provided by

Published in

Links

Tools

Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer